| Ident. | Authors (with country if any) | Title |
|---|
| 000287 (2019) |
Christine M. Oshansky [États-Unis] ; James Zhou [États-Unis] ; Yonghong Gao [États-Unis] ; Jo Ellen Schweinle [États-Unis] ; Karen Biscardi [États-Unis] ; Jennifer Debeauchamp [États-Unis] ; Corrina Pavetto [États-Unis] ; Amy Wollish [États-Unis] ; Richard J. Webby [États-Unis] ; Vittoria Cioce [États-Unis] ; Ruben O. Donis [États-Unis] ; Rick A. Bright [États-Unis] | Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). |
| 000364 (2019) |
Fredrik Granath [Suède] ; Rolf Gedeborg [Suède] ; Hans Smedje [Suède] ; Nils Feltelius [Suède] | Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic. |
| 000549 (2018) |
Dan Zheng [République populaire de Chine] ; Feixia Gao [République populaire de Chine] ; Cheng Zhao [République populaire de Chine] ; Yahong Ding [République populaire de Chine] ; Yemin Cao [République populaire de Chine] ; Tianhan Yang [République populaire de Chine] ; Xuesong Xu [République populaire de Chine] ; Ze Chen [République populaire de Chine] | Comparative effectiveness of H7N9 vaccines in healthy individuals |
| 000730 (2017) |
M. D. Heath ; N. J. Swan ; A. C. Marriott ; N. J. Silman ; B. Hallis ; C. Prevosto ; K. E. Gooch ; M. A. Skinner | Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza |
| 000876 (2016) |
Dan Zheng [République populaire de Chine] ; Shaoheng Chen [République populaire de Chine] ; Di Qu [République populaire de Chine] ; Jianjun Chen [République populaire de Chine] ; Fuyan Wang [République populaire de Chine] ; Ran Zhang [République populaire de Chine] ; Ze Chen [République populaire de Chine] | Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. |
| 000882 (2016) |
David L. Gordon [Australie] ; Dimitar Sajkov [Australie] ; Yoshikazu Honda-Okubo [Australie] ; Samuel H. Wilks [Royaume-Uni] ; Malet Aban [Australie] ; Ian G. Barr [Australie] ; Nikolai Petrovsky [Australie] | Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant |
| 000885 (2016) |
Leora R. Feldstein [États-Unis] ; Laura Matrajt [États-Unis] ; M. Elizabeth Halloran [États-Unis] ; Wendy A. Keitel [États-Unis] ; Ira M. Longini [États-Unis] | Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies |
| 000B84 (2015) |
Lisa A. Jackson [États-Unis] ; James D. Campbell [États-Unis] ; Sharon E. Frey [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Wendy A. Keitel [États-Unis] ; Karen L. Kotloff [États-Unis] ; Andrea A. Berry [États-Unis] ; Irene Graham [États-Unis] ; Robert L. Atmar [États-Unis] ; C Buddy Creech [États-Unis] ; Isaac P. Thomsen [États-Unis] ; Shital M. Patel [États-Unis] ; Andres F. Gutierrez [États-Unis] ; Edwin L. Anderson [États-Unis] ; Hana M. El Sahly [États-Unis] ; Heather Hill [États-Unis] ; Diana L. Noah [États-Unis] ; Abbie R. Bellamy [États-Unis] | Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. |
| 000B93 (2015) |
Tao Qin ; Yinyan Yin ; Qinghua Yu ; Lulu Huang ; Xiaoqing Wang ; Jian Lin ; Qian Yang | CpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa |
| 000C12 (2015) |
Yoshikazu Honda-Okubo [Australie] ; Chun Hao Ong [Australie] ; Nikolai Petrovsky [Australie] | Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection |
| 000E44 (2014) |
Yoko Shoji [États-Unis] ; Alex Prokhnevsky [États-Unis] ; Brett Leffet [États-Unis] ; Nancy Vetter [États-Unis] ; Stephen Tottey [États-Unis] ; Shama Satinover [États-Unis] ; Konstantin Musiychuk [États-Unis] ; Moneim Shamloul [États-Unis] ; Joey Norikane [États-Unis] ; R Mark Jones [États-Unis] ; Jessica A. Chichester [États-Unis] ; Brian J. Green [États-Unis] ; Stephen J. Streatfield [États-Unis] ; Vidadi Yusibov [États-Unis] | Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana |
| 000F00 (2014) |
Keith S. Reisinger [États-Unis] ; Sandra J. Holmes [États-Unis] ; Paola Pedotti [États-Unis] ; Ashwani Kumar Arora [États-Unis] ; Maria Lattanzi [États-Unis] | A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination |
| 001222 (2013) |
Karen K. Yam ; Jyotsana Gupta ; Angela Brewer ; David W. Scheifele ; Scott Halperin ; Brian J. Ward | Unusual Patterns of IgG Avidity in Some Young Children following Two Doses of the Adjuvanted Pandemic H1N1 (2009) Influenza Virus Vaccine |
| 001257 (2013) |
Byoung-Shik Shim [Corée du Sud] ; Jung-Ah Choi ; Ho-Hyun Song ; Sung-Moo Park ; In Su Cheon ; Ji-Eun Jang ; Sun Je Woo ; Chung Hwan Cho ; Min-Suk Song ; Hyemi Kim ; Kyung Joo Song ; Jae Myun Lee ; Suhng Wook Kim ; Dae Sub Song ; Young Ki Choi ; Jae-Ouk Kim ; Huan Huu Nguyen ; Dong Wook Kim ; Young Yil Bahk ; Cheol-Heui Yun ; Man Ki Song | Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus. |
| 001262 (2013) |
Jyothi K. Mallajosyula [États-Unis] ; Ernie Hiatt [États-Unis] ; Steve Hume [États-Unis] ; Ashley Johnson [États-Unis] ; Trushar Jeevan [États-Unis] ; Rachel Chikwamba [Afrique du Sud] ; Gregory P. Pogue [États-Unis] ; Barry Bratcher [États-Unis] ; Hugh Haydon [États-Unis] ; Richard J. Webby [États-Unis] ; Alison A. Mccormick [États-Unis] | Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge |
| 001299 (2013) |
Gregory A. Poland [États-Unis] ; Douglas M. Fleming ; John J. Treanor ; Eugene Maraskovsky ; Thomas C. Luke ; Emma M A. Ball ; Caroline M. Poland | New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. |
| 001402 (2013) |
Christopher B. Fox [États-Unis] ; Jean Haensler | An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. |
| 001403 (2013) |
Silvia Candela [Italie] ; Sara Pergolizzi ; Pietro Ragni ; Silvio Cavuto ; Lucia Nobilio ; Simona Di Mario ; Valentina Dragosevic ; Nicola Groth ; Nicola Magrini | An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one. |
| 001412 (2013) |
Maria Luisa Moro [Italie] ; Lucia Nobilio ; Claudio Voci ; Simona Di Mario ; Silvia Candela ; Nicola Magrini | A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two. |
| 001A11 (2012) |
Takuji Kumagai [Japon] ; Hiroshi Kiyono | Summary for symposium I on the development of a more efficacious influenza vaccine held at the 15th Annual Meeting of the Japanese Society for Vaccinology, Tokyo, 2011. |
| 001A32 (2012) |
Joanne M. Langley [Canada] ; Dennis Reich ; Naresh Aggarwal ; David Connor ; Marc H. Lebel ; Anil Gupta ; Hartley Garfield ; Ping Li ; Anu Madan ; David W. Vaughn | Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. |
